Hematology Hawk Kim
Favorite Doctor
Specialty
Leukemia, bone marrow failure
Clinical Interests
Acute myeloid leukemia
Chronic myeloid leukemia
Myelodysplastic syndromes
Aplastic anemia
Anemia
Thrombocytopenia
Leukopenia
Splenomegaly
Rare blood diseses
Site
Press
Schedule
| Week | M | T | W | T | F | S |
|---|---|---|---|---|---|---|
| AM | ||||||
| PM |
※ The schedule can be changed without notice.
CALL (1577-2299)
Education
| 1995 | Hanyang University College of Medicine, MD |
|---|---|
| 1999 | Hanyang University Graduate College of Medicine, M.S |
| 2007 | Ulsan University Graduate College of Medicine, Ph.D. |
Career
| 1995 | Hanyang University Hospital, Intern |
|---|---|
| 1996 | Department of Internal Medicine, Hanyang University Hospital, Resident |
| 2000 | Army Medical Center Hospital, Medical officer |
| 2003 | Asan Medical Center, Clinical Instructor |
| 2005 | Ulsan University Hospital, Professor |
| 2017~ | Gachon University Gil Medical Center, Professor |
Community
Training
| 2008 | M. D. Anderson Cancer Center |
|---|
License
| 1995 | Medical License |
|---|---|
| 2000 | Internal Medicine Specialist |
| 2006 | Hematology Oncology Specialist |
Paper
| 2019 | Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukemia in the chronic phase (RERISE). |
|---|---|
| 2019 | Age and remission induction therapy for acute myeloid leukemia (AML): from Korean AML registry |
| 2019 | Prospective randomized trial comparing two doses of rabbit antithymocyte globulin in patients with severe aplastic anemia. |
| 2019 | Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome. |
| 2019 | Outcomes of decitabine treatment for newly diagnosed acute myeloid leukemia (AML) in older adults and the role of a mini nutritional assessment short form (MNA-SF). |